메뉴 건너뛰기




Volumn 4, Issue APR, 2013, Pages

Acting on hormone receptors with minimal side effect on cell proliferation: A timely challenge illustrated with GLP-1R and GPER

Author keywords

Adverse effects; Arrestin; Biased ligands; Cancer; Estrogen; G protein; GLP 1; Receptor

Indexed keywords

ANTIESTROGEN; BETA ARRESTIN; CYCLIN D1; ESTROGEN RECEPTOR; EXENDIN 4; G PROTEIN COUPLED RECEPTOR 30; GLIPIZIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; HORMONE RECEPTOR; LIRAGLUTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATEGLINIDE; PANCREATITIS ASSOCIATED PROTEIN; REPAGLINIDE; ROSIGLITAZONE; SOMATOSTATIN RECEPTOR; TAMOXIFEN;

EID: 84884175820     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00050     Document Type: Review
Times cited : (15)

References (234)
  • 1
    • 84861617933 scopus 로고    scopus 로고
    • Review of hormonal treatment of breast cancer
    • Abdulkareem, I. H., and Zurmi, I. B. (2012). Review of hormonal treatment of breast cancer. Niger. J. Clin. Pract. 15, 9-14.
    • (2012) Niger. J. Clin. Pract. , vol.15 , pp. 9-14
    • Abdulkareem, I.H.1    Zurmi, I.B.2
  • 2
    • 67349176115 scopus 로고    scopus 로고
    • Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
    • Ahren, B. (2009). Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug Discov. 8, 369-385.
    • (2009) Nat. Rev. Drug Discov. , vol.8 , pp. 369-385
    • Ahren, B.1
  • 3
    • 33847755409 scopus 로고    scopus 로고
    • G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells
    • Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., et al. (2007). G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 67, 1859-1866.
    • (2007) Cancer Res. , vol.67 , pp. 1859-1866
    • Albanito, L.1    Madeo, A.2    Lappano, R.3    Vivacqua, A.4    Rago, V.5    Carpino, A.6
  • 4
    • 47949111993 scopus 로고    scopus 로고
    • Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells
    • Albanito, L., Sisci, D., Aquila, S., Brunelli, E., Vivacqua, A., Madeo, A., et al. (2008a). Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 149, 3799-3808.
    • (2008) Endocrinology , vol.149 , pp. 3799-3808
    • Albanito, L.1    Sisci, D.2    Aquila, S.3    Brunelli, E.4    Vivacqua, A.5    Madeo, A.6
  • 5
    • 58149331109 scopus 로고    scopus 로고
    • G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells
    • Albanito, L., Lappano, R., Madeo, A., Chimento, A., Prossnitz, E. R., Cappello, A. R., et al. (2008b). G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ. Health Perspect. 116, 1648-1655.
    • (2008) Environ. Health Perspect. , vol.116 , pp. 1648-1655
    • Albanito, L.1    Lappano, R.2    Madeo, A.3    Chimento, A.4    Prossnitz, E.R.5    Cappello, A.R.6
  • 6
    • 81355156238 scopus 로고    scopus 로고
    • Guide to receptors and channels (GRAC), 5th edition
    • Alexander, S. P., Mathie, A., and Peters, J. A. (2011). Guide to receptors and channels (GRAC), 5th edition. Br. J. Pharmacol. 164(Suppl. 1), S1-S324.
    • (2011) Br. J. Pharmacol. , vol.164 , Issue.SUPPL. 1
    • Alexander, S.P.1    Mathie, A.2    Peters, J.A.3
  • 7
    • 84872112695 scopus 로고    scopus 로고
    • The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells
    • Alonzeau, J., Alexandre, D., Jeandel, L., Courel, M., Hautot, C., Yamani, F. Z., et al. (2012). The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells. Eur. J. Cancer. 49, 511-519.
    • (2012) Eur. J. Cancer. , vol.49 , pp. 511-519
    • Alonzeau, J.1    Alexandre, D.2    Jeandel, L.3    Courel, M.4    Hautot, C.5    Yamani, F.Z.6
  • 8
    • 0036174608 scopus 로고    scopus 로고
    • Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function
    • Angers, S., Salahpour, A., and Bouvier, M. (2002). Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435.
    • (2002) Annu. Rev. Pharmacol. Toxicol. , vol.42 , pp. 409-435
    • Angers, S.1    Salahpour, A.2    Bouvier, M.3
  • 9
    • 77950799867 scopus 로고    scopus 로고
    • Liraglutide (Victoza) for type 2 diabetes
    • Anonymous.
    • Anonymous. (2010). Liraglutide (Victoza) for type 2 diabetes. Med. Lett. Drugs Ther. 52, 25-27.
    • (2010) Med. Lett. Drugs Ther. , vol.52 , pp. 25-27
  • 10
    • 84871286519 scopus 로고    scopus 로고
    • Restructuring G-protein- coupled receptor activation
    • Audet, M., and Bouvier, M. (2012). Restructuring G-protein- coupled receptor activation. Cell 151, 14-23.
    • (2012) Cell , vol.151 , pp. 14-23
    • Audet, M.1    Bouvier, M.2
  • 11
    • 34248223285 scopus 로고    scopus 로고
    • Biology of incretins: GLP-1 and GIP
    • Baggio, L. L., and Drucker, D. J. (2007). Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157.
    • (2007) Gastroenterology , vol.132 , pp. 2131-2157
    • Baggio, L.L.1    Drucker, D.J.2
  • 12
    • 33847373003 scopus 로고    scopus 로고
    • Early discontinuation of tamoxifen: a lesson for oncologists
    • Barron, T. I., Connolly, R., Bennett, K., Feely, J., and Kennedy, M. J. (2007). Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 109, 832-839.
    • (2007) Cancer , vol.109 , pp. 832-839
    • Barron, T.I.1    Connolly, R.2    Bennett, K.3    Feely, J.4    Kennedy, M.J.5
  • 15
    • 9644254427 scopus 로고    scopus 로고
    • Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo
    • Bierkamp, C., Bonhoure, S., Mathieu, A., Clerc, P., Fourmy, D., Pradayrol, L., et al. (2004). Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo. Am. J. Pathol. 165, 2135-2145.
    • (2004) Am. J. Pathol. , vol.165 , pp. 2135-2145
    • Bierkamp, C.1    Bonhoure, S.2    Mathieu, A.3    Clerc, P.4    Fourmy, D.5    Pradayrol, L.6
  • 16
    • 0037064132 scopus 로고    scopus 로고
    • Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations
    • Bisello, A., Chorev, M., Rosenblatt, M., Monticelli, L., Mierke, D. F., and Ferrari, S. L. (2002). Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J. Biol. Chem. 277, 38524-38530.
    • (2002) J. Biol. Chem. , vol.277 , pp. 38524-38530
    • Bisello, A.1    Chorev, M.2    Rosenblatt, M.3    Monticelli, L.4    Mierke, D.F.5    Ferrari, S.L.6
  • 17
    • 77950228684 scopus 로고    scopus 로고
    • Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation
    • Bjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., et al. (2010). Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology 151, 1473-1486.
    • (2010) Endocrinology , vol.151 , pp. 1473-1486
    • Bjerre Knudsen, L.1    Madsen, L.W.2    Andersen, S.3    Almholt, K.4    de Boer, A.S.5    Drucker, D.J.6
  • 19
    • 2542479899 scopus 로고    scopus 로고
    • Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
    • Brubaker, P. L., and Drucker, D. J. (2004). Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145, 2653-2659.
    • (2004) Endocrinology , vol.145 , pp. 2653-2659
    • Brubaker, P.L.1    Drucker, D.J.2
  • 20
    • 84865020296 scopus 로고    scopus 로고
    • Effect of exendin (exenatide)-GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model
    • Bulchandani, D., Nachnani, J. S., Herndon, B., Molteni, A., Pathan, M. H., Quinn, T., et al. (2012). Effect of exendin (exenatide)-GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model. Eur. J. Pharmacol. 691, 292-296.
    • (2012) Eur. J. Pharmacol. , vol.691 , pp. 292-296
    • Bulchandani, D.1    Nachnani, J.S.2    Herndon, B.3    Molteni, A.4    Pathan, M.H.5    Quinn, T.6
  • 21
    • 84867565635 scopus 로고    scopus 로고
    • Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30
    • doi:10.1371/journal.pone.0046861
    • Burai, R., Ramesh, C., Nayak, T. K., Dennis, M. K., Bryant, B. K., Prossnitz, E. R., et al. (2012). Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30. PLoS ONE 7:e46861. doi:10.1371/journal.pone.0046861
    • (2012) PLoS ONE , vol.7
    • Burai, R.1    Ramesh, C.2    Nayak, T.K.3    Dennis, M.K.4    Bryant, B.K.5    Prossnitz, E.R.6
  • 22
    • 84859267187 scopus 로고    scopus 로고
    • G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors
    • Burch, M. L., Osman, N., Getachew, R., Al-Aryahi, S., Poronnik, P., Zheng, W., et al. (2012). G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors. Int. J. Biochem. Cell Biol. 44, 722-727.
    • (2012) Int. J. Biochem. Cell Biol. , vol.44 , pp. 722-727
    • Burch, M.L.1    Osman, N.2    Getachew, R.3    Al-Aryahi, S.4    Poronnik, P.5    Zheng, W.6
  • 23
    • 67649666737 scopus 로고    scopus 로고
    • Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
    • Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., et al. (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 374, 39-47.
    • (2009) Lancet , vol.374 , pp. 39-47
    • Buse, J.B.1    Rosenstock, J.2    Sesti, G.3    Schmidt, W.E.4    Montanya, E.5    Brett, J.H.6
  • 24
    • 84856759440 scopus 로고    scopus 로고
    • Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes
    • Busnelli, M., Sauliere, A., Manning, M., Bouvier, M., Gales, C., and Chini, B. (2012). Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J. Biol. Chem. 287, 3617-3629.
    • (2012) J. Biol. Chem. , vol.287 , pp. 3617-3629
    • Busnelli, M.1    Sauliere, A.2    Manning, M.3    Bouvier, M.4    Gales, C.5    Chini, B.6
  • 25
    • 0037221488 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor
    • Buteau, J., Foisy, S., Joly, E., and Prentki, M. (2003). Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52, 124-132.
    • (2003) Diabetes , vol.52 , pp. 124-132
    • Buteau, J.1    Foisy, S.2    Joly, E.3    Prentki, M.4
  • 26
    • 0031282001 scopus 로고    scopus 로고
    • Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer
    • Carmeci, C., Thompson, D. A., Ring, H. Z., Francke, U., and Weigel, R. J. (1997). Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45, 607-617.
    • (1997) Genomics , vol.45 , pp. 607-617
    • Carmeci, C.1    Thompson, D.A.2    Ring, H.Z.3    Francke, U.4    Weigel, R.J.5
  • 27
    • 33746600263 scopus 로고    scopus 로고
    • Estrogen receptor target gene: an evolving concept
    • Carroll, J. S., and Brown, M. (2006). Estrogen receptor target gene: an evolving concept. Mol. Endocrinol. 20, 1707-1714.
    • (2006) Mol. Endocrinol. , vol.20 , pp. 1707-1714
    • Carroll, J.S.1    Brown, M.2
  • 28
    • 33746519903 scopus 로고    scopus 로고
    • Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells
    • Cayrol, C., Clerc, P., Bertrand, C., Gigoux, V., Portolan, G., Fourmy, D., et al. (2006). Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells. Oncogene 25, 4421-4428.
    • (2006) Oncogene , vol.25 , pp. 4421-4428
    • Cayrol, C.1    Clerc, P.2    Bertrand, C.3    Gigoux, V.4    Portolan, G.5    Fourmy, D.6
  • 29
    • 73549093367 scopus 로고    scopus 로고
    • Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways
    • Cescato, R., Loesch, K. A., Waser, B., Macke, H. R., Rivier, J. E., Reubi, J. C., et al. (2010). Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways. Mol. Endocrinol. 24, 240-249.
    • (2010) Mol. Endocrinol. , vol.24 , pp. 240-249
    • Cescato, R.1    Loesch, K.A.2    Waser, B.3    Macke, H.R.4    Rivier, J.E.5    Reubi, J.C.6
  • 30
    • 77955711650 scopus 로고    scopus 로고
    • Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest
    • Chan, Q. K., Lam, H. M., Ng, C. F., Lee, A. Y., Chan, E. S., Ng, H. K., et al. (2010). Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ. 17, 1511-1523.
    • (2010) Cell Death Differ. , vol.17 , pp. 1511-1523
    • Chan, Q.K.1    Lam, H.M.2    Ng, C.F.3    Lee, A.Y.4    Chan, E.S.5    Ng, H.K.6
  • 31
    • 0038353630 scopus 로고    scopus 로고
    • The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose
    • Chang, A. M., Jakobsen, G., Sturis, J., Smith, M. J., Bloem, C. J., An, B., et al. (2003). The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose. Diabetes 52, 1786-1791.
    • (2003) Diabetes , vol.52 , pp. 1786-1791
    • Chang, A.M.1    Jakobsen, G.2    Sturis, J.3    Smith, M.J.4    Bloem, C.J.5    An, B.6
  • 32
    • 57349130733 scopus 로고    scopus 로고
    • Estrogen and its receptors in cancer
    • Chen, G. G., Zeng, Q., and Tse, G. M. (2008). Estrogen and its receptors in cancer. Med. Res. Rev. 28, 954-974.
    • (2008) Med. Res. Rev. , vol.28 , pp. 954-974
    • Chen, G.G.1    Zeng, Q.2    Tse, G.M.3
  • 33
    • 79959870180 scopus 로고    scopus 로고
    • Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus
    • Cheng, S. B., Graeber, C. T., Quinn, J. A., and Filardo, E. J. (2011). Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids 76, 892-896.
    • (2011) Steroids , vol.76 , pp. 892-896
    • Cheng, S.B.1    Graeber, C.T.2    Quinn, J.A.3    Filardo, E.J.4
  • 34
    • 80055119745 scopus 로고    scopus 로고
    • Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30
    • Chevalier, N., Bouskine, A., and Fenichel, P. (2012). Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int. J. Cancer 130, 241-242.
    • (2012) Int. J. Cancer , vol.130 , pp. 241-242
    • Chevalier, N.1    Bouskine, A.2    Fenichel, P.3
  • 35
    • 53749085064 scopus 로고    scopus 로고
    • Incretin-based therapies in type 2 diabetes mellitus
    • Chia, C. W., and Egan, J. M. (2008). Incretin-based therapies in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 93, 3703-3716.
    • (2008) J. Clin. Endocrinol. Metab. , vol.93 , pp. 3703-3716
    • Chia, C.W.1    Egan, J.M.2
  • 36
    • 78649353120 scopus 로고    scopus 로고
    • Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a review
    • Christ, E., Wild, D., and Reubi, J. C. (2010). Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a review. Endocrinol. Metab. Clin. North Am. 39, 791-800.
    • (2010) Endocrinol. Metab. Clin. North Am. , vol.39 , pp. 791-800
    • Christ, E.1    Wild, D.2    Reubi, J.C.3
  • 37
    • 80053357815 scopus 로고    scopus 로고
    • Conformational changes in the G protein Gs induced by the beta2 adrenergic receptor
    • Chung, K. Y., Rasmussen, S. G., Liu, T., Li, S., DeVree, B. T., Chae, P. S., et al. (2011). Conformational changes in the G protein Gs induced by the beta2 adrenergic receptor. Nature 477, 611-615.
    • (2011) Nature , vol.477 , pp. 611-615
    • Chung, K.Y.1    Rasmussen, S.G.2    Liu, T.3    Li, S.4    DeVree, B.T.5    Chae, P.S.6
  • 39
    • 0036161385 scopus 로고    scopus 로고
    • Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia
    • Clerc, P., Leung-Theung-Long, S., Wang, T. C., Dockray, G. J., Bouisson, M., Delisle, M. B., et al. (2002a). Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia. Gastroenterology 122, 428-437.
    • (2002) Gastroenterology , vol.122 , pp. 428-437
    • Clerc, P.1    Leung-Theung-Long, S.2    Wang, T.C.3    Dockray, G.J.4    Bouisson, M.5    Delisle, M.B.6
  • 41
    • 77956191559 scopus 로고    scopus 로고
    • The vasoactive intestinal peptide-receptor system is involved in human glioblastoma cell migration
    • Cochaud, S., Chevrier, L., Meunier, A. C., Brillet, T., Chadeneau, C., and Muller, J. M. (2010). The vasoactive intestinal peptide-receptor system is involved in human glioblastoma cell migration. Neuropeptides 44, 373-383.
    • (2010) Neuropeptides , vol.44 , pp. 373-383
    • Cochaud, S.1    Chevrier, L.2    Meunier, A.C.3    Brillet, T.4    Chadeneau, C.5    Muller, J.M.6
  • 42
    • 33846964878 scopus 로고    scopus 로고
    • Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules
    • Costante, G., Meringolo, D., Durante, C., Bianchi, D., Nocera, M., Tumino, S., et al. (2007). Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J. Clin. Endocrinol. Metab. 92, 450-455.
    • (2007) J. Clin. Endocrinol. Metab. , vol.92 , pp. 450-455
    • Costante, G.1    Meringolo, D.2    Durante, C.3    Bianchi, D.4    Nocera, M.5    Tumino, S.6
  • 43
    • 42949112670 scopus 로고    scopus 로고
    • Exenatide and rare adverse events
    • discussion 1971-1972
    • Cure, P., Pileggi, A., and Alejandro, R. (2008). Exenatide and rare adverse events. N. Engl. J. Med. 358, 1969-1970; discussion 1971-1972.
    • (2008) N. Engl. J. Med. , vol.358 , pp. 1969-1970
    • Cure, P.1    Pileggi, A.2    Alejandro, R.3
  • 44
    • 33646354927 scopus 로고    scopus 로고
    • Exenatide (exendin-4)-induced pancreatitis: a case report
    • Denker, P. S., and Dimarco, P. E. (2006). Exenatide (exendin-4)-induced pancreatitis: a case report. Diabetes Care 29, 471.
    • (2006) Diabetes Care , vol.29 , pp. 471
    • Denker, P.S.1    Dimarco, P.E.2
  • 47
    • 33644638521 scopus 로고    scopus 로고
    • Estrogen receptors and human disease
    • Deroo, B. J., and Korach, K. S. (2006). Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570.
    • (2006) J. Clin. Invest. , vol.116 , pp. 561-570
    • Deroo, B.J.1    Korach, K.S.2
  • 48
    • 33847617011 scopus 로고    scopus 로고
    • Mechanisms of action of glucagon-like peptide 1 in the pancreas
    • Doyle, M. E., and Egan, J. M. (2007). Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol. Ther. 113, 546-593.
    • (2007) Pharmacol. Ther. , vol.113 , pp. 546-593
    • Doyle, M.E.1    Egan, J.M.2
  • 49
    • 0037312818 scopus 로고    scopus 로고
    • Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis
    • Drucker, D. J. (2003). Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol. Endocrinol. 17, 161-171.
    • (2003) Mol. Endocrinol. , vol.17 , pp. 161-171
    • Drucker, D.J.1
  • 50
    • 33644618433 scopus 로고    scopus 로고
    • The biology of incretin hormones
    • Drucker, D. J. (2006). The biology of incretin hormones. Cell Metab. 3, 153-165.
    • (2006) Cell Metab. , vol.3 , pp. 153-165
    • Drucker, D.J.1
  • 51
    • 84862822293 scopus 로고    scopus 로고
    • The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells
    • Du, G. Q., Zhou, L., Chen, X. Y., Wan, X. P., and He, Y. Y. (2012a). The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. Biochem. Biophys. Res. Commun. 420, 343-349.
    • (2012) Biochem. Biophys. Res. Commun. , vol.420 , pp. 343-349
    • Du, G.Q.1    Zhou, L.2    Chen, X.Y.3    Wan, X.P.4    He, Y.Y.5
  • 52
    • 84860752363 scopus 로고    scopus 로고
    • Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling
    • Du, N., Feng, J., Hu, L. J., Sun, X., Sun, H. B., Zhao, Y., et al. (2012b). Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol. Rep. 27, 1893-1903.
    • (2012) Oncol. Rep. , vol.27 , pp. 1893-1903
    • Du, N.1    Feng, J.2    Hu, L.J.3    Sun, X.4    Sun, H.B.5    Zhao, Y.6
  • 53
    • 33644841711 scopus 로고    scopus 로고
    • Cholecystokinin and gastrin receptors
    • Dufresne, M., Seva, C., and Fourmy, D. (2006). Cholecystokinin and gastrin receptors. Physiol. Rev. 86, 805-847.
    • (2006) Physiol. Rev. , vol.86 , pp. 805-847
    • Dufresne, M.1    Seva, C.2    Fourmy, D.3
  • 54
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG). (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687-1717.
    • (2005) Lancet , vol.365 , pp. 1687-1717
  • 55
    • 15744393640 scopus 로고    scopus 로고
    • Regulation of signal transduction pathways by estrogen and progesterone
    • Edwards, D. P. (2005). Regulation of signal transduction pathways by estrogen and progesterone. Annu. Rev. Physiol. 67, 335-376.
    • (2005) Annu. Rev. Physiol. , vol.67 , pp. 335-376
    • Edwards, D.P.1
  • 56
    • 79959559653 scopus 로고    scopus 로고
    • Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
    • Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., and Butler, P. C. (2011). Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 141, 150-156.
    • (2011) Gastroenterology , vol.141 , pp. 150-156
    • Elashoff, M.1    Matveyenko, A.V.2    Gier, B.3    Elashoff, R.4    Butler, P.C.5
  • 57
    • 10744223544 scopus 로고    scopus 로고
    • Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders
    • Elisei, R., Bottici, V., Luchetti, F., Di Coscio, G., Romei, C., Grasso, L., et al. (2004). Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab. 89, 163-168.
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 163-168
    • Elisei, R.1    Bottici, V.2    Luchetti, F.3    Di Coscio, G.4    Romei, C.5    Grasso, L.6
  • 58
    • 84884186582 scopus 로고    scopus 로고
    • European Medicines Agency (EMA) [accessed September]
    • European Medicines Agency (EMA). (2006). Assessment Report for Byetta. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000698/WC500051842.pdf [accessed September 27, 2011].
    • (2006) Assessment Report for Byetta. Available at , vol.27
  • 59
    • 84884171865 scopus 로고    scopus 로고
    • European Medicines Agency (EMA) [accessed September]
    • European Medicines Agency (EMA). (2009). Assessment report for Victoza. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016. pdf [accessed September 27, 2011].
    • (2009) Assessment report for Victoza. Available at , vol.27 , pp. 2011
  • 60
    • 84884182744 scopus 로고    scopus 로고
    • European Medicines Agency (EMA)[accessed September]
    • European Medicines Agency (EMA). (2011). Assessment Report for By-Dureon. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002020/WC500108239.pdf [accessed September 27, 2011].
    • (2011) Assessment Report for By-Dureon. Available at , vol.27 , pp. 2011
  • 62
    • 77957919319 scopus 로고    scopus 로고
    • Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1
    • Fernandez-Martinez, A. B., Bajo, A. M., Isabel Arenas, M., Sanchez-Chapado, M., Prieto, J. C., and Carmena, M. J. (2010). Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1. Cancer Lett. 299, 11-21.
    • (2010) Cancer Lett. , vol.299 , pp. 11-21
    • Fernandez-Martinez, A.B.1    Bajo, A.M.2    Isabel Arenas, M.3    Sanchez-Chapado, M.4    Prieto, J.C.5    Carmena, M.J.6
  • 63
    • 33751272253 scopus 로고    scopus 로고
    • Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression
    • Filardo, E. J., Graeber, C. T., Quinn, J. A., Resnick, M. B., Giri, D., DeLellis, R. A., et al. (2006). Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin. Cancer Res. 12, 6359-6366.
    • (2006) Clin. Cancer Res. , vol.12 , pp. 6359-6366
    • Filardo, E.J.1    Graeber, C.T.2    Quinn, J.A.3    Resnick, M.B.4    Giri, D.5    DeLellis, R.A.6
  • 64
    • 0033780783 scopus 로고    scopus 로고
    • Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
    • Filardo, E. J., Quinn, J. A., Bland, K. I., and Frackelton, A. R. Jr. (2000). Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14, 1649-1660.
    • (2000) Mol. Endocrinol. , vol.14 , pp. 1649-1660
    • Filardo, E.J.1    Quinn, J.A.2    Bland, K.I.3    Frackelton, A.R.Jr.4
  • 66
    • 78650186098 scopus 로고    scopus 로고
    • Expression and in vitro functions of the ghrelin axis in endometrial cancer
    • Fung, J. N., Seim, I., Wang, D., Obermair, A., Chopin, L. K., and Chen, C. (2010). Expression and in vitro functions of the ghrelin axis in endometrial cancer. Horm. Cancer 1, 245-255.
    • (2010) Horm. Cancer , vol.1 , pp. 245-255
    • Fung, J.N.1    Seim, I.2    Wang, D.3    Obermair, A.4    Chopin, L.K.5    Chen, C.6
  • 67
    • 73949084919 scopus 로고    scopus 로고
    • A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation
    • Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., et al. (2009). A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci. Transl. Med. 1, 1ra1.
    • (2009) Sci. Transl. Med. , vol.1
    • Gesty-Palmer, D.1    Flannery, P.2    Yuan, L.3    Corsino, L.4    Spurney, R.5    Lefkowitz, R.J.6
  • 68
    • 79961236811 scopus 로고    scopus 로고
    • Biasing the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?
    • Gesty-Palmer, D., and Luttrell, L. M. (2011). "Biasing" the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass? Br. J. Pharmacol. 164, 59-67.
    • (2011) Br. J. Pharmacol. , vol.164 , pp. 59-67
    • Gesty-Palmer, D.1    Luttrell, L.M.2
  • 70
    • 84860567470 scopus 로고    scopus 로고
    • Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
    • Gier, B., Matveyenko, A. V., Kirakossian, D., Dawson, D., Dry, S. M., and Butler, P. C. (2012a). Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model. Diabetes 61, 1250-1262.
    • (2012) Diabetes , vol.61 , pp. 1250-1262
    • Gier, B.1    Matveyenko, A.V.2    Kirakossian, D.3    Dawson, D.4    Dry, S.M.5    Butler, P.C.6
  • 74
    • 77955016889 scopus 로고    scopus 로고
    • Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes
    • Girman, C. J., Kou, T. D., Cai, B., Alexander, C. M., O'Neill, E. A., Williams-Herman, D. E., et al. (2010). Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes. Metab. 12, 766-771.
    • (2010) Diabetes Obes. Metab. , vol.12 , pp. 766-771
    • Girman, C.J.1    Kou, T.D.2    Cai, B.3    Alexander, C.M.4    O'Neill, E.A.5    Williams-Herman, D.E.6
  • 75
    • 0027184119 scopus 로고
    • Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
    • Goke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., et al. (1993). Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J. Biol. Chem. 268, 19650-19655.
    • (1993) J. Biol. Chem. , vol.268 , pp. 19650-19655
    • Goke, R.1    Fehmann, H.C.2    Linn, T.3    Schmidt, H.4    Krause, M.5    Eng, J.6
  • 76
    • 0035687010 scopus 로고    scopus 로고
    • The effect of SERMs on the endometrium
    • Goldstein, S. R. (2001). The effect of SERMs on the endometrium. Ann. N. Y. Acad. Sci. 949, 237-242.
    • (2001) Ann. N. Y. Acad. Sci. , vol.949 , pp. 237-242
    • Goldstein, S.R.1
  • 77
    • 0023915865 scopus 로고
    • Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse
    • Gottardis, M. M., Robinson, S. P., Satyaswaroop, P. G., and Jordan, V. C. (1988). Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res. 48, 812-815.
    • (1988) Cancer Res. , vol.48 , pp. 812-815
    • Gottardis, M.M.1    Robinson, S.P.2    Satyaswaroop, P.G.3    Jordan, V.C.4
  • 78
    • 33646788425 scopus 로고    scopus 로고
    • Exocrine meets endocrine: pancreatic stone protein and regenerating protein-two sides of the same coin
    • Graf, R., Schiesser, M., Reding, T., Appenzeller, P., Sun, L. K., Fortunato, F., et al. (2006). Exocrine meets endocrine: pancreatic stone protein and regenerating protein-two sides of the same coin. J. Surg. Res. 133, 113-120.
    • (2006) J. Surg. Res. , vol.133 , pp. 113-120
    • Graf, R.1    Schiesser, M.2    Reding, T.3    Appenzeller, P.4    Sun, L.K.5    Fortunato, F.6
  • 79
    • 34250376066 scopus 로고    scopus 로고
    • Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies
    • Granier, S., Kim, S., Shafer, A. M., Ratnala, V. R., Fung, J. J., Zare, R. N., et al. (2007). Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies. J. Biol. Chem. 282, 13895-13905.
    • (2007) J. Biol. Chem. , vol.282 , pp. 13895-13905
    • Granier, S.1    Kim, S.2    Shafer, A.M.3    Ratnala, V.R.4    Fung, J.J.5    Zare, R.N.6
  • 80
    • 68849105055 scopus 로고    scopus 로고
    • Inflammation and pancreatic cancer: an evidence-based review
    • Greer, J. B., and Whitcomb, D. C. (2009). Inflammation and pancreatic cancer: an evidence-based review. Curr. Opin. Pharmacol. 9, 411-418.
    • (2009) Curr. Opin. Pharmacol. , vol.9 , pp. 411-418
    • Greer, J.B.1    Whitcomb, D.C.2
  • 81
    • 78651306525 scopus 로고    scopus 로고
    • Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells
    • Grieco, P., Franco, R., Bozzuto, G., Toccacieli, L., Sgambato, A., Marra, M., et al. (2011). Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. J. Cell. Biochem. 112, 341-353.
    • (2011) J. Cell. Biochem. , vol.112 , pp. 341-353
    • Grieco, P.1    Franco, R.2    Bozzuto, G.3    Toccacieli, L.4    Sgambato, A.5    Marra, M.6
  • 83
    • 84866485226 scopus 로고    scopus 로고
    • Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation
    • Hafiz, S., Dennis, J. C., Schwartz, D., Judd, R., Tao, Y. X., Khazal, K., et al. (2012). Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation. Int. J. Oncol. 41, 1373-1380.
    • (2012) Int. J. Oncol. , vol.41 , pp. 1373-1380
    • Hafiz, S.1    Dennis, J.C.2    Schwartz, D.3    Judd, R.4    Tao, Y.X.5    Khazal, K.6
  • 84
    • 37349081370 scopus 로고    scopus 로고
    • Extranuclear steroid receptors: nature and actions
    • Hammes, S. R., and Levin, E. R. (2007). Extranuclear steroid receptors: nature and actions. Endocr. Rev. 28, 726-741.
    • (2007) Endocr. Rev. , vol.28 , pp. 726-741
    • Hammes, S.R.1    Levin, E.R.2
  • 85
    • 84868585481 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery
    • Harikumar, K. G., Wootten, D., Pinon, D. I., Koole, C., Ball, A. M., Furness, S. G., et al. (2012). Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery. Proc. Natl. Acad. Sci. U.S.A. 109, 18607-18612.
    • (2012) Proc. Natl. Acad. Sci. U.S.A. , vol.109 , pp. 18607-18612
    • Harikumar, K.G.1    Wootten, D.2    Pinon, D.I.3    Koole, C.4    Ball, A.M.5    Furness, S.G.6
  • 86
    • 67649888455 scopus 로고    scopus 로고
    • Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway
    • He, Y. Y., Cai, B., Yang, Y. X., Liu, X. L., and Wan, X. P. (2009). Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci. 100, 1051-1061.
    • (2009) Cancer Sci. , vol.100 , pp. 1051-1061
    • He, Y.Y.1    Cai, B.2    Yang, Y.X.3    Liu, X.L.4    Wan, X.P.5
  • 87
    • 84862303608 scopus 로고    scopus 로고
    • Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2
    • He, Y. Y., Du, G. Q., Cai, B., Yan, Q., Zhou, L., Chen, X. Y., et al. (2012). Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2. J. Cancer Res. Clin. Oncol. 138, 775-783.
    • (2012) J. Cancer Res. Clin. Oncol. , vol.138 , pp. 775-783
    • He, Y.Y.1    Du, G.Q.2    Cai, B.3    Yan, Q.4    Zhou, L.5    Chen, X.Y.6
  • 88
    • 79952284556 scopus 로고    scopus 로고
    • GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide
    • Hegedus, L., Moses, A. C., Zdravkovic, M., Le Thi, T., and Daniels, G. H. (2011). GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide. J. Clin. Endocrinol. Metab. 96, 853-860.
    • (2011) J. Clin. Endocrinol. Metab. , vol.96 , pp. 853-860
    • Hegedus, L.1    Moses, A.C.2    Zdravkovic, M.3    Le Thi, T.4    Daniels, G.H.5
  • 89
    • 65649135116 scopus 로고    scopus 로고
    • Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells
    • Henic, E., Noskova, V., Hoyer-Hansen, G., Hansson, S., and Casslen, B. (2009). Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells. Int. J. Gynecol. Cancer 19, 214-222.
    • (2009) Int. J. Gynecol. Cancer , vol.19 , pp. 214-222
    • Henic, E.1    Noskova, V.2    Hoyer-Hansen, G.3    Hansson, S.4    Casslen, B.5
  • 90
    • 49849101934 scopus 로고    scopus 로고
    • Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution
    • Hernandez-Munoz, I., Skoudy, A., Real, F. X., and Navarro, P. (2008). Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution. Pancreatology 8, 462-469.
    • (2008) Pancreatology , vol.8 , pp. 462-469
    • Hernandez-Munoz, I.1    Skoudy, A.2    Real, F.X.3    Navarro, P.4
  • 91
    • 21344454577 scopus 로고    scopus 로고
    • Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use
    • Hodsman, A. B., Bauer, D. C., Dempster, D. W., Dian, L., Hanley, D. A., Harris, S. T., et al. (2005). Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr. Rev. 26, 688-703.
    • (2005) Endocr. Rev. , vol.26 , pp. 688-703
    • Hodsman, A.B.1    Bauer, D.C.2    Dempster, D.W.3    Dian, L.4    Hanley, D.A.5    Harris, S.T.6
  • 92
    • 35748957503 scopus 로고    scopus 로고
    • The physiology of glucagon-like peptide 1
    • Holst, J. J. (2007). The physiology of glucagon-like peptide 1. Physiol. Rev. 87, 1409-1439.
    • (2007) Physiol. Rev. , vol.87 , pp. 1409-1439
    • Holst, J.J.1
  • 93
    • 0030876081 scopus 로고    scopus 로고
    • The pathogenesis of NIDDM involves a defective expression of the GIP receptor
    • Holst, J. J., Gromada, J., and Nauck, M. A. (1997). The pathogenesis of NIDDM involves a defective expression of the GIP receptor. Diabetologia 40, 984-986.
    • (1997) Diabetologia , vol.40 , pp. 984-986
    • Holst, J.J.1    Gromada, J.2    Nauck, M.A.3
  • 94
    • 0347990624 scopus 로고    scopus 로고
    • Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell
    • Holz, G. G. (2004). Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 53, 5-13.
    • (2004) Diabetes , vol.53 , pp. 5-13
    • Holz, G.G.1
  • 96
    • 0343632386 scopus 로고    scopus 로고
    • Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat
    • Horsch, D., Goke, R., Eissele, R., Michel, B., and Goke, B. (1997). Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat. Pancreas 14, 290-294.
    • (1997) Pancreas , vol.14 , pp. 290-294
    • Horsch, D.1    Goke, R.2    Eissele, R.3    Michel, B.4    Goke, B.5
  • 99
    • 77955771545 scopus 로고    scopus 로고
    • Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
    • Ignatov, A., Ignatov, T., Roessner, A., Costa, S. D., and Kalinski, T. (2010b). Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res. Treat. 123, 87-96.
    • (2010) Breast Cancer Res. Treat. , vol.123 , pp. 87-96
    • Ignatov, A.1    Ignatov, T.2    Roessner, A.3    Costa, S.D.4    Kalinski, T.5
  • 100
    • 0025892130 scopus 로고
    • The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa)
    • Jamil, A., Croxtall, J. D., and White, J. O. (1991). The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa). J. Mol. Endocrinol. 6, 215-221.
    • (1991) J. Mol. Endocrinol. , vol.6 , pp. 215-221
    • Jamil, A.1    Croxtall, J.D.2    White, J.O.3
  • 101
    • 0036123510 scopus 로고    scopus 로고
    • Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
    • Jeffery, P. L., Herington, A. C., and Chopin, L. K. (2002). Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J. Endocrinol. 172, R7-R11.
    • (2002) J. Endocrinol. , vol.172
    • Jeffery, P.L.1    Herington, A.C.2    Chopin, L.K.3
  • 102
    • 28544446509 scopus 로고    scopus 로고
    • Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines
    • Jeffery, P. L., Murray, R. E., Yeh, A. H., McNamara, J. F., Duncan, R. P., Francis, G. D., et al. (2005). Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr. Relat. Cancer 12, 839-850.
    • (2005) Endocr. Relat. Cancer , vol.12 , pp. 839-850
    • Jeffery, P.L.1    Murray, R.E.2    Yeh, A.H.3    McNamara, J.F.4    Duncan, R.P.5    Francis, G.D.6
  • 103
    • 0033578005 scopus 로고    scopus 로고
    • G-protein-coupled receptor heterodimerization modulates receptor function
    • Jordan, B. A., and Devi, L. A. (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700.
    • (1999) Nature , vol.399 , pp. 697-700
    • Jordan, B.A.1    Devi, L.A.2
  • 104
    • 33947714587 scopus 로고    scopus 로고
    • SERMs: meeting the promise of multifunctional medicines
    • Jordan, V. C. (2007). SERMs: meeting the promise of multifunctional medicines. J. Natl. Cancer Inst. 99, 350-356.
    • (2007) J. Natl. Cancer Inst. , vol.99 , pp. 350-356
    • Jordan, V.C.1
  • 105
    • 0033304703 scopus 로고    scopus 로고
    • Tamoxifen, raloxifene, and the prevention of breast cancer
    • Jordan, V. C., and Morrow, M. (1999). Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr. Rev. 20, 253-278.
    • (1999) Endocr. Rev. , vol.20 , pp. 253-278
    • Jordan, V.C.1    Morrow, M.2
  • 106
    • 34250714898 scopus 로고    scopus 로고
    • Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s)
    • Jorgensen, R., Kubale, V., Vrecl, M., Schwartz, T. W., and Elling, C. E. (2007). Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s). J. Pharmacol. Exp. Ther. 322, 148-154.
    • (2007) J. Pharmacol. Exp. Ther. , vol.322 , pp. 148-154
    • Jorgensen, R.1    Kubale, V.2    Vrecl, M.3    Schwartz, T.W.4    Elling, C.E.5
  • 107
    • 77951203576 scopus 로고    scopus 로고
    • Aromatase inhibitors versus tamoxifen as adjuvant hormonal therapy for oestrogen sensitive early breast cancer in post-menopausal women: meta-analyses of monotherapy, sequenced therapy and extended therapy
    • Josefsson, M. L., and Leinster, S. J. (2010). Aromatase inhibitors versus tamoxifen as adjuvant hormonal therapy for oestrogen sensitive early breast cancer in post-menopausal women: meta-analyses of monotherapy, sequenced therapy and extended therapy. Breast 19, 76-83.
    • (2010) Breast , vol.19 , pp. 76-83
    • Josefsson, M.L.1    Leinster, S.J.2
  • 108
    • 19644363283 scopus 로고    scopus 로고
    • Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between
    • Jura, N., Archer, H., and Bar-Sagi, D. (2005). Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between. Cell Res. 15, 72-77.
    • (2005) Cell Res. , vol.15 , pp. 72-77
    • Jura, N.1    Archer, H.2    Bar-Sagi, D.3
  • 109
    • 80052967337 scopus 로고    scopus 로고
    • Multiple ligand-specific conformations of the beta2-adrenergic receptor
    • Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., et al. (2011). Multiple ligand-specific conformations of the beta2-adrenergic receptor. Nat. Chem. Biol. 7, 692-700.
    • (2011) Nat. Chem. Biol. , vol.7 , pp. 692-700
    • Kahsai, A.W.1    Xiao, K.2    Rajagopal, S.3    Ahn, S.4    Shukla, A.K.5    Sun, J.6
  • 110
    • 0035824548 scopus 로고    scopus 로고
    • Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion
    • Kashima, Y., Miki, T., Shibasaki, T., Ozaki, N., Miyazaki, M., Yano, H., et al. (2001). Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J. Biol. Chem. 276, 46046-46053.
    • (2001) J. Biol. Chem. , vol.276 , pp. 46046-46053
    • Kashima, Y.1    Miki, T.2    Shibasaki, T.3    Ozaki, N.4    Miyazaki, M.5    Yano, H.6
  • 111
    • 61849136239 scopus 로고    scopus 로고
    • Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway
    • Ketterer, K., Kong, B., Frank, D., Giese, N. A., Bauer, A., Hoheisel, J., et al. (2009). Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway. Cancer Lett. 277, 72-81.
    • (2009) Cancer Lett. , vol.277 , pp. 72-81
    • Ketterer, K.1    Kong, B.2    Frank, D.3    Giese, N.A.4    Bauer, A.5    Hoheisel, J.6
  • 112
    • 55749084393 scopus 로고    scopus 로고
    • Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation
    • Kim, I. M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., et al. (2008). Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc. Natl. Acad. Sci. U.S.A. 105, 14555-14560.
    • (2008) Proc. Natl. Acad. Sci. U.S.A. , vol.105 , pp. 14555-14560
    • Kim, I.M.1    Tilley, D.G.2    Chen, J.3    Salazar, N.C.4    Whalen, E.J.5    Violin, J.D.6
  • 113
    • 57149102903 scopus 로고    scopus 로고
    • Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer
    • Kintzel, P. E., Chase, S. L., Schultz, L. M., and O'Rourke, T. J. (2008). Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. Pharmacotherapy 28, 1511-1522.
    • (2008) Pharmacotherapy , vol.28 , pp. 1511-1522
    • Kintzel, P.E.1    Chase, S.L.2    Schultz, L.M.3    O'Rourke, T.J.4
  • 114
    • 57349134539 scopus 로고    scopus 로고
    • 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30
    • Kleuser, B., Malek, D., Gust, R., Pertz, H. H., and Potteck, H. (2008). 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30. Mol. Pharmacol. 74, 1533-1543.
    • (2008) Mol. Pharmacol. , vol.74 , pp. 1533-1543
    • Kleuser, B.1    Malek, D.2    Gust, R.3    Pertz, H.H.4    Potteck, H.5
  • 115
    • 70349120958 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice
    • Koehler, J. A., Baggio, L. L., Lamont, B. J., Ali, S., and Drucker, D. J. (2009). Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice. Diabetes 58, 2148-2161.
    • (2009) Diabetes , vol.58 , pp. 2148-2161
    • Koehler, J.A.1    Baggio, L.L.2    Lamont, B.J.3    Ali, S.4    Drucker, D.J.5
  • 116
    • 33745320855 scopus 로고    scopus 로고
    • Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells
    • Koehler, J. A., and Drucker, D. J. (2006). Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells. Diabetes 55, 1369-1379.
    • (2006) Diabetes , vol.55 , pp. 1369-1379
    • Koehler, J.A.1    Drucker, D.J.2
  • 117
    • 34250635159 scopus 로고    scopus 로고
    • GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting
    • Korner, M., Stockli, M., Waser, B., and Reubi, J. C. (2007). GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J. Nucl. Med. 48, 736-743.
    • (2007) J. Nucl. Med. , vol.48 , pp. 736-743
    • Korner, M.1    Stockli, M.2    Waser, B.3    Reubi, J.C.4
  • 118
    • 84864674632 scopus 로고    scopus 로고
    • Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting
    • Lando, H. M., Alattar, M., and Dua, A. P. (2012). Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting. Endocr. Pract. 18, 472-477.
    • (2012) Endocr. Pract. , vol.18 , pp. 472-477
    • Lando, H.M.1    Alattar, M.2    Dua, A.P.3
  • 120
    • 34047275592 scopus 로고    scopus 로고
    • Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens
    • Leblanc, K., Sexton, E., Parent, S., Belanger, G., Dery, M. C., Boucher, V., et al. (2007). Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens. Int. J. Oncol. 30, 477-487.
    • (2007) Int. J. Oncol. , vol.30 , pp. 477-487
    • Leblanc, K.1    Sexton, E.2    Parent, S.3    Belanger, G.4    Dery, M.C.5    Boucher, V.6
  • 121
    • 79959564813 scopus 로고    scopus 로고
    • Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
    • Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G., et al. (2011). Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 474, 521-525.
    • (2011) Nature , vol.474 , pp. 521-525
    • Lebon, G.1    Warne, T.2    Edwards, P.C.3    Bennett, K.4    Langmead, C.J.5    Leslie, A.G.6
  • 122
    • 77951622241 scopus 로고    scopus 로고
    • The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin
    • Lee, D. K., Ferguson, S. S., George, S. R., and O'Dowd, B. F. (2010). The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin. Biochem. Biophys. Res. Commun. 395, 185-189.
    • (2010) Biochem. Biophys. Res. Commun. , vol.395 , pp. 185-189
    • Lee, D.K.1    Ferguson, S.S.2    George, S.R.3    O'Dowd, B.F.4
  • 123
    • 84862776738 scopus 로고    scopus 로고
    • Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR
    • Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., and Wuthrich, K. (2012). Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR. Science 335, 1106-1110.
    • (2012) Science , vol.335 , pp. 1106-1110
    • Liu, J.J.1    Horst, R.2    Katritch, V.3    Stevens, R.C.4    Wuthrich, K.5
  • 125
    • 71849107983 scopus 로고    scopus 로고
    • Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer
    • Logsdon, C. D., and Ji, B. (2009). Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin. Gastroenterol. Hepatol. 7, S40-S43.
    • (2009) Clin. Gastroenterol. Hepatol. , vol.7
    • Logsdon, C.D.1    Ji, B.2
  • 126
    • 77957958535 scopus 로고    scopus 로고
    • Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens
    • Lorand, T., Vigh, E., and Garai, J. (2010). Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens. Curr. Med. Chem. 17, 3542-3574.
    • (2010) Curr. Med. Chem. , vol.17 , pp. 3542-3574
    • Lorand, T.1    Vigh, E.2    Garai, J.3
  • 127
    • 77958017639 scopus 로고    scopus 로고
    • Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy
    • Lu, C., Everhart, L., Tilan, J., Kuo, L., Sun, C. C., Munivenkatappa, R. B., et al. (2010). Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene 29, 5630-5642.
    • (2010) Oncogene , vol.29 , pp. 5630-5642
    • Lu, C.1    Everhart, L.2    Tilan, J.3    Kuo, L.4    Sun, C.C.5    Munivenkatappa, R.B.6
  • 128
    • 77952415656 scopus 로고    scopus 로고
    • Beyond desensitization: physiological relevance of arrestin-dependent signaling
    • Luttrell, L. M., and Gesty-Palmer, D. (2010). Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol. Rev. 62, 305-330.
    • (2010) Pharmacol. Rev. , vol.62 , pp. 305-330
    • Luttrell, L.M.1    Gesty-Palmer, D.2
  • 129
    • 0346732301 scopus 로고    scopus 로고
    • Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways
    • MacDonald, P. E., Wang, X., Xia, F., El-kholy, W., Targonsky, E. D., Tsushima, R. G., et al. (2003). Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways. J. Biol. Chem. 278, 52446-52453.
    • (2003) J. Biol. Chem. , vol.278 , pp. 52446-52453
    • MacDonald, P.E.1    Wang, X.2    Xia, F.3    El-kholy, W.4    Targonsky, E.D.5    Tsushima, R.G.6
  • 130
    • 72549112513 scopus 로고    scopus 로고
    • Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer
    • Machens, A., Hoffmann, F., Sekulla, C., and Dralle, H. (2009). Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr. Relat. Cancer 16, 1291-1298.
    • (2009) Endocr. Relat. Cancer , vol.16 , pp. 1291-1298
    • Machens, A.1    Hoffmann, F.2    Sekulla, C.3    Dralle, H.4
  • 131
    • 59349108585 scopus 로고    scopus 로고
    • Treatment of type 2 diabetes with incretin-based therapies
    • Madsbad, S. (2009). Treatment of type 2 diabetes with incretin-based therapies. Lancet 373, 438-439.
    • (2009) Lancet , vol.373 , pp. 438-439
    • Madsbad, S.1
  • 132
    • 84857422717 scopus 로고    scopus 로고
    • GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation
    • Madsen, L. W., Knauf, J. A., Gotfredsen, C., Pilling, A., Sjogren, I., Andersen, S., et al. (2012). GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology 153, 1538-1547.
    • (2012) Endocrinology , vol.153 , pp. 1538-1547
    • Madsen, L.W.1    Knauf, J.A.2    Gotfredsen, C.3    Pilling, A.4    Sjogren, I.5    Andersen, S.6
  • 133
    • 17644406373 scopus 로고    scopus 로고
    • Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation
    • Mathieu, A., Clerc, P., Portolan, G., Bierkamp, C., Lulka, H., Pradayrol, L., et al. (2005). Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation. Int. J. Cancer 115, 46-54.
    • (2005) Int. J. Cancer , vol.115 , pp. 46-54
    • Mathieu, A.1    Clerc, P.2    Portolan, G.3    Bierkamp, C.4    Lulka, H.5    Pradayrol, L.6
  • 136
    • 0000661662 scopus 로고    scopus 로고
    • The molecular pharmacology of SERMs
    • McDonnell, D. P. (1999). The molecular pharmacology of SERMs. Trends Endocrinol. Metab. 10, 301-311.
    • (1999) Trends Endocrinol. Metab. , vol.10 , pp. 301-311
    • McDonnell, D.P.1
  • 137
    • 24944441782 scopus 로고    scopus 로고
    • Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates
    • Means, A. L., Meszoely, I. M., Suzuki, K., Miyamoto, Y., Rustgi, A. K., Coffey, R. J., et al. (2005). Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132, 3767-3776.
    • (2005) Development , vol.132 , pp. 3767-3776
    • Means, A.L.1    Meszoely, I.M.2    Suzuki, K.3    Miyamoto, Y.4    Rustgi, A.K.5    Coffey, R.J.6
  • 139
    • 72849129415 scopus 로고    scopus 로고
    • The comorbidity of diabetes mellitus and psychiatric disorders
    • Medved, V., Jovanovic, N., and Knapic, V. P. (2009). The comorbidity of diabetes mellitus and psychiatric disorders. Psychiatr. Danub. 21, 585-588.
    • (2009) Psychiatr. Danub. , vol.21 , pp. 585-588
    • Medved, V.1    Jovanovic, N.2    Knapic, V.P.3
  • 140
    • 68949131242 scopus 로고    scopus 로고
    • ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis
    • Meyer, M. R., and Barton, M. (2009). ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc. Res. 83, 605-610.
    • (2009) Cardiovasc. Res. , vol.83 , pp. 605-610
    • Meyer, M.R.1    Barton, M.2
  • 141
    • 67449152265 scopus 로고    scopus 로고
    • Non-genomic regulation of vascular cell function and growth by estrogen
    • Meyer, M. R., Haas, E., Prossnitz, E. R., and Barton, M. (2009). Non-genomic regulation of vascular cell function and growth by estrogen. Mol. Cell. Endocrinol. 308, 9-16.
    • (2009) Mol. Cell. Endocrinol. , vol.308 , pp. 9-16
    • Meyer, M.R.1    Haas, E.2    Prossnitz, E.R.3    Barton, M.4
  • 142
    • 0023107555 scopus 로고
    • Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
    • Mojsov, S., Weir, G. C., and Habener, J. F. (1987). Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79, 616-619.
    • (1987) J. Clin. Invest. , vol.79 , pp. 616-619
    • Mojsov, S.1    Weir, G.C.2    Habener, J.F.3
  • 143
    • 77955274496 scopus 로고    scopus 로고
    • Prokineticins in angiogenesis and cancer
    • Monnier, J., and Samson, M. (2010). Prokineticins in angiogenesis and cancer. Cancer Lett. 296, 144-149.
    • (2010) Cancer Lett. , vol.296 , pp. 144-149
    • Monnier, J.1    Samson, M.2
  • 144
    • 84861549027 scopus 로고    scopus 로고
    • Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells
    • Moody, T. W., Osefo, N., Nuche-Berenguer, B., Ridnour, L., Wink, D., and Jensen, R. T. (2012). Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. J. Pharmacol. Exp. Ther. 341, 873-881.
    • (2012) J. Pharmacol. Exp. Ther. , vol.341 , pp. 873-881
    • Moody, T.W.1    Osefo, N.2    Nuche-Berenguer, B.3    Ridnour, L.4    Wink, D.5    Jensen, R.T.6
  • 146
    • 80053348156 scopus 로고    scopus 로고
    • Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells
    • doi:10.1186/1471-2407-11-421
    • Muller, K. M., Tveteraas, I. H., Aasrum, M., Odegard, J., Dawood, M., Dajani, O., et al. (2011). Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells. BMC Cancer 11:421. doi:10.1186/1471-2407-11-421
    • (2011) BMC Cancer , vol.11 , pp. 421
    • Muller, K.M.1    Tveteraas, I.H.2    Aasrum, M.3    Odegard, J.4    Dawood, M.5    Dajani, O.6
  • 148
    • 84864621482 scopus 로고    scopus 로고
    • Reduced intestinal tumorigenesis in APCmin mice lacking melanin-concentrating hormone
    • doi:10.1371/journal.pone.0041914
    • Nagel, J. M., Geiger, B. M., Karagiannis, A. K., Gras-Miralles, B., Horst, D., Najarian, R. M., et al. (2012). Reduced intestinal tumorigenesis in APCmin mice lacking melanin-concentrating hormone. PLoS ONE 7:e41914. doi:10.1371/journal.pone.0041914
    • (2012) PLoS ONE , vol.7
    • Nagel, J.M.1    Geiger, B.M.2    Karagiannis, A.K.3    Gras-Miralles, B.4    Horst, D.5    Najarian, R.M.6
  • 149
    • 37249034101 scopus 로고    scopus 로고
    • Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
    • Nasrallah, H. A. (2008). Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol. Psychiatry 13, 27-35.
    • (2008) Mol. Psychiatry , vol.13 , pp. 27-35
    • Nasrallah, H.A.1
  • 150
    • 0027391607 scopus 로고
    • Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
    • Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., and Creutzfeldt, W. (1993). Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91, 301-307.
    • (1993) J. Clin. Invest. , vol.91 , pp. 301-307
    • Nauck, M.A.1    Heimesaat, M.M.2    Orskov, C.3    Holst, J.J.4    Ebert, R.5    Creutzfeldt, W.6
  • 151
    • 75549091061 scopus 로고    scopus 로고
    • Incretin-based therapies: viewpoints on the way to consensus
    • Nauck, M. A., Vilsboll, T., Gallwitz, B., Garber, A., and Madsbad, S. (2009). Incretin-based therapies: viewpoints on the way to consensus. Diabetes Care 32(Suppl. 2), S223-S231.
    • (2009) Diabetes Care , vol.32 , Issue.SUPPL. 2
    • Nauck, M.A.1    Vilsboll, T.2    Gallwitz, B.3    Garber, A.4    Madsbad, S.5
  • 152
    • 84860577431 scopus 로고    scopus 로고
    • The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species
    • Nyborg, N. C., Molck, A. M., Madsen, L. W., and Knudsen, L. B. (2012). The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species. Diabetes 61, 1243-1249.
    • (2012) Diabetes , vol.61 , pp. 1243-1249
    • Nyborg, N.C.1    Molck, A.M.2    Madsen, L.W.3    Knudsen, L.B.4
  • 154
    • 53249107839 scopus 로고    scopus 로고
    • G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol
    • Otto, C., Rohde-Schulz, B., Schwarz, G., Fuchs, I., Klewer, M., Brittain, D., et al. (2008). G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 149, 4846-4856.
    • (2008) Endocrinology , vol.149 , pp. 4846-4856
    • Otto, C.1    Rohde-Schulz, B.2    Schwarz, G.3    Fuchs, I.4    Klewer, M.5    Brittain, D.6
  • 156
    • 62049084027 scopus 로고    scopus 로고
    • Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
    • Pandey, D. P., Lappano, R., Albanito, L., Madeo, A., Maggiolini, M., and Picard, D. (2009). Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 28, 523-532.
    • (2009) EMBO J. , vol.28 , pp. 523-532
    • Pandey, D.P.1    Lappano, R.2    Albanito, L.3    Madeo, A.4    Maggiolini, M.5    Picard, D.6
  • 157
    • 80053304908 scopus 로고    scopus 로고
    • Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo
    • Park, H. J., Kim, S. R., Kim, M. K., Choi, K. S., Jang, H. O., Yun, I., et al. (2011). Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo. Cancer Lett. 312, 117-127.
    • (2011) Cancer Lett. , vol.312 , pp. 117-127
    • Park, H.J.1    Kim, S.R.2    Kim, M.K.3    Choi, K.S.4    Jang, H.O.5    Yun, I.6
  • 158
    • 33644850386 scopus 로고    scopus 로고
    • Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function
    • Park, S., Dong, X., Fisher, T. L., Dunn, S., Omer, A. K., Weir, G., et al. (2006). Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J. Biol. Chem. 281, 1159-1168.
    • (2006) J. Biol. Chem. , vol.281 , pp. 1159-1168
    • Park, S.1    Dong, X.2    Fisher, T.L.3    Dunn, S.4    Omer, A.K.5    Weir, G.6
  • 159
    • 33747841976 scopus 로고    scopus 로고
    • Nature of functional estrogen receptors at the plasma membrane
    • Pedram, A., Razandi, M., and Levin, E. R. (2006). Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20, 1996-2009.
    • (2006) Mol. Endocrinol. , vol.20 , pp. 1996-2009
    • Pedram, A.1    Razandi, M.2    Levin, E.R.3
  • 160
    • 84860112131 scopus 로고    scopus 로고
    • What we have learned about pancreatic cancer from mouse models
    • Perez-Mancera, P. A., Guerra, C., Barbacid, M., and Tuveson, D. A. (2012). What we have learned about pancreatic cancer from mouse models. Gastroenterology 142, 1079-1092.
    • (2012) Gastroenterology , vol.142 , pp. 1079-1092
    • Perez-Mancera, P.A.1    Guerra, C.2    Barbacid, M.3    Tuveson, D.A.4
  • 162
    • 4444373076 scopus 로고    scopus 로고
    • Prevention of cancers of the breast, endometrium and ovary
    • Pike, M. C., Pearce, C. L., and Wu, A. H. (2004). Prevention of cancers of the breast, endometrium and ovary. Oncogene 23, 6379-6391.
    • (2004) Oncogene , vol.23 , pp. 6379-6391
    • Pike, M.C.1    Pearce, C.L.2    Wu, A.H.3
  • 163
    • 34548612361 scopus 로고    scopus 로고
    • Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat
    • Piteau, S., Olver, A., Kim, S. J., Winter, K., Pospisilik, J. A., Lynn, F., et al. (2007). Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat. Biochem. Biophys. Res. Commun. 362, 1007-1012.
    • (2007) Biochem. Biophys. Res. Commun. , vol.362 , pp. 1007-1012
    • Piteau, S.1    Olver, A.2    Kim, S.J.3    Winter, K.4    Pospisilik, J.A.5    Lynn, F.6
  • 164
    • 33847773775 scopus 로고    scopus 로고
    • Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial
    • Powles, T. J., Ashley, S., Tidy, A., Smith, I. E., and Dowsett, M. (2007). Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J. Natl. Cancer Inst. 99, 283-290.
    • (2007) J. Natl. Cancer Inst. , vol.99 , pp. 283-290
    • Powles, T.J.1    Ashley, S.2    Tidy, A.3    Smith, I.E.4    Dowsett, M.5
  • 165
    • 60549097258 scopus 로고    scopus 로고
    • Targeting incretins in Type 2 diabetes: role of GLP-1 receptor agonists and DPP-4 inhibitors
    • Pratley, R. E., and Gilbert, M. (2008). Targeting incretins in Type 2 diabetes: role of GLP-1 receptor agonists and DPP-4 inhibitors. Rev. Diabet. Stud. 5, 73-94.
    • (2008) Rev. Diabet. Stud. , vol.5 , pp. 73-94
    • Pratley, R.E.1    Gilbert, M.2
  • 168
    • 76249122645 scopus 로고    scopus 로고
    • GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells
    • Quoyer, J., Longuet, C., Broca, C., Linck, N., Costes, S., Varin, E., et al. (2010). GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. J. Biol. Chem. 285, 1989-2002.
    • (2010) J. Biol. Chem. , vol.285 , pp. 1989-2002
    • Quoyer, J.1    Longuet, C.2    Broca, C.3    Linck, N.4    Costes, S.5    Varin, E.6
  • 169
    • 68149160827 scopus 로고    scopus 로고
    • An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis
    • Rafei, M., Berchiche, Y. A., Birman, E., Boivin, M. N., Young, Y. K., Wu, J. H., et al. (2009). An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. J. Immunol. 183, 1759-1766.
    • (2009) J. Immunol. , vol.183 , pp. 1759-1766
    • Rafei, M.1    Berchiche, Y.A.2    Birman, E.3    Boivin, M.N.4    Young, Y.K.5    Wu, J.H.6
  • 170
    • 84860201432 scopus 로고    scopus 로고
    • Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy
    • Rahmeh, R., Damian, M., Cottet, M., Orcel, H., Mendre, C., Durroux, T., et al. (2012). Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 109, 6733-6738.
    • (2012) Proc. Natl. Acad. Sci. U.S.A. , vol.109 , pp. 6733-6738
    • Rahmeh, R.1    Damian, M.2    Cottet, M.3    Orcel, H.4    Mendre, C.5    Durroux, T.6
  • 171
    • 77951844975 scopus 로고    scopus 로고
    • Teaching old receptors new tricks: biasing seven-transmembrane receptors
    • Rajagopal, S., Rajagopal, K., and Lefkowitz, R. J. (2010a). Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9, 373-386.
    • (2010) Nat. Rev. Drug Discov. , vol.9 , pp. 373-386
    • Rajagopal, S.1    Rajagopal, K.2    Lefkowitz, R.J.3
  • 172
  • 174
    • 14844343093 scopus 로고    scopus 로고
    • A transmembrane intracellular estrogen receptor mediates rapid cell signaling
    • Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., and Prossnitz, E. R. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630.
    • (2005) Science , vol.307 , pp. 1625-1630
    • Revankar, C.M.1    Cimino, D.F.2    Sklar, L.A.3    Arterburn, J.B.4    Prossnitz, E.R.5
  • 175
    • 18144422077 scopus 로고    scopus 로고
    • The oxytocin receptor antagonist atosiban inhibits cell growth via a biased agonist mechanism
    • Reversi, A., Rimoldi, V., Marrocco, T., Cassoni, P., Bussolati, G., Parenti, M., et al. (2005). The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J. Biol. Chem. 280, 16311-16318.
    • (2005) J. Biol. Chem. , vol.280 , pp. 16311-16318
    • Reversi, A.1    Rimoldi, V.2    Marrocco, T.3    Cassoni, P.4    Bussolati, G.5    Parenti, M.6
  • 176
    • 11244296162 scopus 로고    scopus 로고
    • Mechanisms of tamoxifen resistance
    • Ring, A., and Dowsett, M. (2004). Mechanisms of tamoxifen resistance. Endocr. Relat. Cancer 11, 643-658.
    • (2004) Endocr. Relat. Cancer , vol.11 , pp. 643-658
    • Ring, A.1    Dowsett, M.2
  • 177
    • 0034677745 scopus 로고    scopus 로고
    • Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers
    • Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., and Patel, Y. C. (2000). Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 275, 7862-7869.
    • (2000) J. Biol. Chem. , vol.275 , pp. 7862-7869
    • Rocheville, M.1    Lange, D.C.2    Kumar, U.3    Sasi, R.4    Patel, R.C.5    Patel, Y.C.6
  • 180
    • 32644453155 scopus 로고    scopus 로고
    • Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells
    • Ruscica, M., Dozio, E., Boghossian, S., Bovo, G., Martos Riano, V., Motta, M., et al. (2006). Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells. Endocrinology 147, 1466-1473.
    • (2006) Endocrinology , vol.147 , pp. 1466-1473
    • Ruscica, M.1    Dozio, E.2    Boghossian, S.3    Bovo, G.4    Martos Riano, V.5    Motta, M.6
  • 181
    • 79951987933 scopus 로고    scopus 로고
    • G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments
    • Sanden, C., Broselid, S., Cornmark, L., Andersson, K., Daszkiewicz-Nilsson, J., Martensson, U. E., et al. (2011). G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol. Pharmacol. 79, 400-410.
    • (2011) Mol. Pharmacol. , vol.79 , pp. 400-410
    • Sanden, C.1    Broselid, S.2    Cornmark, L.3    Andersson, K.4    Daszkiewicz-Nilsson, J.5    Martensson, U.E.6
  • 182
    • 0029759541 scopus 로고    scopus 로고
    • Annual hazard rates of recurrence for breast cancer after primary therapy
    • Saphner, T., Tormey, D. C., and Gray, R. (1996). Annual hazard rates of recurrence for breast cancer after primary therapy. J. Clin. Oncol. 14, 2738-2746.
    • (1996) J. Clin. Oncol. , vol.14 , pp. 2738-2746
    • Saphner, T.1    Tormey, D.C.2    Gray, R.3
  • 183
    • 64049106282 scopus 로고    scopus 로고
    • Metabolic complications of androgen deprivation therapy for prostate cancer
    • discussion 2007-2008
    • Saylor, P. J., and Smith, M. R. (2009). Metabolic complications of androgen deprivation therapy for prostate cancer. J. Urol. 181, 1998-2006. discussion 2007-2008.
    • (2009) J. Urol. , vol.181 , pp. 1998-2006
    • Saylor, P.J.1    Smith, M.R.2
  • 185
    • 25444520038 scopus 로고    scopus 로고
    • PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis
    • Seino, S., and Shibasaki, T. (2005). PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol. Rev. 85, 1303-1342.
    • (2005) Physiol. Rev. , vol.85 , pp. 1303-1342
    • Seino, S.1    Shibasaki, T.2
  • 186
    • 78649348967 scopus 로고    scopus 로고
    • Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress
    • Sengupta, S., Peterson, T. R., and Sabatini, D. M. (2010). Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40, 310-322.
    • (2010) Mol. Cell , vol.40 , pp. 310-322
    • Sengupta, S.1    Peterson, T.R.2    Sabatini, D.M.3
  • 187
    • 42249096282 scopus 로고    scopus 로고
    • Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate
    • Sensken, S. C., Staubert, C., Keul, P., Levkau, B., Schoneberg, T., and Graler, M. H. (2008). Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate. Cell. Signal. 20, 1125-1133.
    • (2008) Cell. Signal. , vol.20 , pp. 1125-1133
    • Sensken, S.C.1    Staubert, C.2    Keul, P.3    Levkau, B.4    Schoneberg, T.5    Graler, M.H.6
  • 188
    • 77951152245 scopus 로고    scopus 로고
    • Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line
    • Sheriff, S., Ali, M., Yahya, A., Haider, K. H., Balasubramaniam, A., and Amlal, H. (2010). Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Mol. Cancer Res. 8, 604-614.
    • (2010) Mol. Cancer Res. , vol.8 , pp. 604-614
    • Sheriff, S.1    Ali, M.2    Yahya, A.3    Haider, K.H.4    Balasubramaniam, A.5    Amlal, H.6
  • 190
    • 33947697810 scopus 로고    scopus 로고
    • GPR30: a novel indicator of poor survival for endometrial carcinoma
    • discussion 386.e9-386.e11
    • Smith, H. O., Leslie, K. K., Singh, M., Qualls, C. R., Revankar, C. M., Joste, N. E., et al. (2007). GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 196, 386.e1-386.e9. discussion 386.e9-386.e11.
    • (2007) Am. J. Obstet. Gynecol. , vol.196
    • Smith, H.O.1    Leslie, K.K.2    Singh, M.3    Qualls, C.R.4    Revankar, C.M.5    Joste, N.E.6
  • 192
    • 84857781490 scopus 로고    scopus 로고
    • Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells
    • Suzuki, K., Nakabayashi, K., Yamada, A. Y., Lodhi, R. S., Hazama, R., Ebina, Y., et al. (2012). Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells. Fertil. Steril. 97, 734-741.
    • (2012) Fertil. Steril. , vol.97 , pp. 734-741
    • Suzuki, K.1    Nakabayashi, K.2    Yamada, A.Y.3    Lodhi, R.S.4    Hazama, R.5    Ebina, Y.6
  • 193
    • 84858287886 scopus 로고    scopus 로고
    • Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders
    • Tack, J., Camilleri, M., Chang, L., Chey, W. D., Galligan, J. J., Lacy, B. E., et al. (2012). Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment. Pharmacol. Ther. 35, 745-767.
    • (2012) Aliment. Pharmacol. Ther. , vol.35 , pp. 745-767
    • Tack, J.1    Camilleri, M.2    Chang, L.3    Chey, W.D.4    Galligan, J.J.5    Lacy, B.E.6
  • 195
    • 33750992478 scopus 로고    scopus 로고
    • Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption
    • Thomas, P., and Dong, J. (2006). Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 102, 175-179.
    • (2006) J. Steroid Biochem. Mol. Biol. , vol.102 , pp. 175-179
    • Thomas, P.1    Dong, J.2
  • 196
    • 12344307170 scopus 로고    scopus 로고
    • Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells
    • Thomas, P., Pang, Y., Filardo, E. J., and Dong, J. (2005). Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146, 624-632.
    • (2005) Endocrinology , vol.146 , pp. 624-632
    • Thomas, P.1    Pang, Y.2    Filardo, E.J.3    Dong, J.4
  • 197
    • 0026775150 scopus 로고
    • Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1
    • Thorens, B. (1992). Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U.S.A. 89, 8641-8645.
    • (1992) Proc. Natl. Acad. Sci. U.S.A. , vol.89 , pp. 8641-8645
    • Thorens, B.1
  • 198
    • 84865348887 scopus 로고    scopus 로고
    • The proliferative effects of ghrelin on human gastric cancer AGS cells
    • Tian, P. Y., and Fan, X. M. (2012). The proliferative effects of ghrelin on human gastric cancer AGS cells. J. Dig. Dis. 13, 453-458.
    • (2012) J. Dig. Dis. , vol.13 , pp. 453-458
    • Tian, P.Y.1    Fan, X.M.2
  • 201
    • 23844487799 scopus 로고    scopus 로고
    • The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells
    • Trumper, J., Ross, D., Jahr, H., Brendel, M. D., Goke, R., and Horsch, D. (2005). The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells. Diabetologia 48, 1534-1540.
    • (2005) Diabetologia , vol.48 , pp. 1534-1540
    • Trumper, J.1    Ross, D.2    Jahr, H.3    Brendel, M.D.4    Goke, R.5    Horsch, D.6
  • 202
    • 84884172044 scopus 로고    scopus 로고
    • Victoza (Liraglutide [rDNA Origin]) Injection: REMS-Risk of Thyroid C-Cell Tumors, Acute Pancreatitis
    • U.S. Food and Drug Administration., Available at [accessed April]
    • U.S. Food and Drug Administration. (2011). Victoza (Liraglutide [rDNA Origin]) Injection: REMS-Risk of Thyroid C-Cell Tumors, Acute Pancreatitis. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm [accessed April 30, 2012].
    • (2011) , vol.30 , pp. 2012
  • 203
    • 78149496656 scopus 로고    scopus 로고
    • The role of conformational ensembles of seven transmembrane receptors in functional selectivity
    • Vaidehi, N., and Kenakin, T. (2010). The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr. Opin. Pharmacol. 10, 775-781.
    • (2010) Curr. Opin. Pharmacol. , vol.10 , pp. 775-781
    • Vaidehi, N.1    Kenakin, T.2
  • 204
    • 80755138420 scopus 로고    scopus 로고
    • RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells
    • Valdehita, A., Carmena, M. J., Bajo, A. M., and Prieto, J. C. (2012). RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells. Mol. Cell. Endocrinol. 348, 241-246.
    • (2012) Mol. Cell. Endocrinol. , vol.348 , pp. 241-246
    • Valdehita, A.1    Carmena, M.J.2    Bajo, A.M.3    Prieto, J.C.4
  • 206
    • 84884195180 scopus 로고    scopus 로고
    • Victoza (Liraglutide) Injection [accessed April]
    • Victoza (Liraglutide) Injection. (2012). Novo Nordisk. Available at: http://www.novo-pi.com/victoza.pdf [accessed April 30, 2012].
    • (2012) Novo Nordisk. Available at , vol.30 , pp. 2012
  • 208
    • 73349106529 scopus 로고    scopus 로고
    • The effects of glucagon-like peptide-1 on the beta cell
    • Vilsboll, T. (2009). The effects of glucagon-like peptide-1 on the beta cell. Diabetes Obes. Metab. 11(Suppl. 3), 11-18.
    • (2009) Diabetes Obes. Metab. , vol.11 , Issue.SUPPL. 3 , pp. 11-18
    • Vilsboll, T.1
  • 209
    • 39749143348 scopus 로고    scopus 로고
    • Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
    • Vilsboll, T., Brock, B., Perrild, H., Levin, K., Lervang, H. H., Kolendorf, K., et al. (2008). Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. Diabet. Med. 25, 152-156.
    • (2008) Diabet. Med. , vol.25 , pp. 152-156
    • Vilsboll, T.1    Brock, B.2    Perrild, H.3    Levin, K.4    Lervang, H.H.5    Kolendorf, K.6
  • 210
    • 0036373430 scopus 로고    scopus 로고
    • Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients
    • Vilsboll, T., Krarup, T., Madsbad, S., and Holst, J. J. (2002). Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia 45, 1111-1119.
    • (2002) Diabetologia , vol.45 , pp. 1111-1119
    • Vilsboll, T.1    Krarup, T.2    Madsbad, S.3    Holst, J.J.4
  • 211
    • 34249869806 scopus 로고    scopus 로고
    • Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes
    • Vilsboll, T., Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Courreges, J. P., et al. (2007). Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes. Diabetes Care 30, 1608-1610.
    • (2007) Diabetes Care , vol.30 , pp. 1608-1610
    • Vilsboll, T.1    Zdravkovic, M.2    Le-Thi, T.3    Krarup, T.4    Schmitz, O.5    Courreges, J.P.6
  • 212
    • 33344461590 scopus 로고    scopus 로고
    • The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells
    • Vivacqua, A., Bonofiglio, D., Recchia, A. G., Musti, A. M., Picard, D., Ando, S., et al. (2006a). The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol. Endocrinol. 20, 631-646.
    • (2006) Mol. Endocrinol. , vol.20 , pp. 631-646
    • Vivacqua, A.1    Bonofiglio, D.2    Recchia, A.G.3    Musti, A.M.4    Picard, D.5    Ando, S.6
  • 213
    • 33748923143 scopus 로고    scopus 로고
    • 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30
    • Vivacqua, A., Bonofiglio, D., Albanito, L., Madeo, A., Rago, V., Carpino, A., et al. (2006b). 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30. Mol. Pharmacol. 70, 1414-1423.
    • (2006) Mol. Pharmacol. , vol.70 , pp. 1414-1423
    • Vivacqua, A.1    Bonofiglio, D.2    Albanito, L.3    Madeo, A.4    Rago, V.5    Carpino, A.6
  • 214
    • 84872024032 scopus 로고    scopus 로고
    • Emerging opportunities for allosteric modulation of G-protein coupled receptors
    • Wang, C. I., and Lewis, R. J. (2013). Emerging opportunities for allosteric modulation of G-protein coupled receptors. Biochem. Pharmacol. 85, 153-162.
    • (2013) Biochem. Pharmacol. , vol.85 , pp. 153-162
    • Wang, C.I.1    Lewis, R.J.2
  • 215
    • 77955334004 scopus 로고    scopus 로고
    • G protein-coupled receptor 30 in tumor development
    • Wang, D., Hu, L., Zhang, G., Zhang, L., and Chen, C. (2010). G protein-coupled receptor 30 in tumor development. Endocrine 38, 29-37.
    • (2010) Endocrine , vol.38 , pp. 29-37
    • Wang, D.1    Hu, L.2    Zhang, G.3    Zhang, L.4    Chen, C.5
  • 216
    • 78651405537 scopus 로고    scopus 로고
    • The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor
    • Warne, T., Moukhametzianov, R., Baker, J. G., Nehme, R., Edwards, P. C., Leslie, A. G., et al. (2011). The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature 469, 241-244.
    • (2011) Nature , vol.469 , pp. 241-244
    • Warne, T.1    Moukhametzianov, R.2    Baker, J.G.3    Nehme, R.4    Edwards, P.C.5    Leslie, A.G.6
  • 217
    • 83655191987 scopus 로고    scopus 로고
    • Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy
    • Waser, B., Beetschen, K., Pellegata, N. S., and Reubi, J. C. (2011). Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy. Neuroendocrinology 94, 291-301.
    • (2011) Neuroendocrinology , vol.94 , pp. 291-301
    • Waser, B.1    Beetschen, K.2    Pellegata, N.S.3    Reubi, J.C.4
  • 218
    • 84856776511 scopus 로고    scopus 로고
    • Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors
    • Waser, B., Rehmann, R., Sanchez, C., Fourmy, D., and Reubi, J. C. (2012). Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors. J. Clin. Endocrinol. Metab. 97, 482-488.
    • (2012) J. Clin. Endocrinol. Metab. , vol.97 , pp. 482-488
    • Waser, B.1    Rehmann, R.2    Sanchez, C.3    Fourmy, D.4    Reubi, J.C.5
  • 219
    • 77954473787 scopus 로고    scopus 로고
    • Selective modulation of follicle-stimulating hormone signaling pathways with enhancing equine chorionic gonadotropin/antibody immune complexes
    • Wehbi, V., Decourtye, J., Piketty, V., Durand, G., Reiter, E., and Maurel, M. C. (2010). Selective modulation of follicle-stimulating hormone signaling pathways with enhancing equine chorionic gonadotropin/antibody immune complexes. Endocrinology 151, 2788-2799.
    • (2010) Endocrinology , vol.151 , pp. 2788-2799
    • Wehbi, V.1    Decourtye, J.2    Piketty, V.3    Durand, G.4    Reiter, E.5    Maurel, M.C.6
  • 220
    • 0031000789 scopus 로고    scopus 로고
    • Specific, nongenomic actions of steroid hormones
    • Wehling, M. (1997). Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59, 365-393.
    • (1997) Annu. Rev. Physiol. , vol.59 , pp. 365-393
    • Wehling, M.1
  • 221
    • 0141703263 scopus 로고    scopus 로고
    • Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
    • Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., et al. (2003). Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 100, 10782-10787.
    • (2003) Proc. Natl. Acad. Sci. U.S.A. , vol.100 , pp. 10782-10787
    • Wei, H.1    Ahn, S.2    Shenoy, S.K.3    Karnik, S.S.4    Hunyady, L.5    Luttrell, L.M.6
  • 222
    • 84862912924 scopus 로고    scopus 로고
    • Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation
    • Wei, Y., Zhang, Z., Liao, H., Wu, L., Wu, X., Zhou, D., et al. (2012). Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Oncol. Rep. 27, 504-510.
    • (2012) Oncol. Rep. , vol.27 , pp. 504-510
    • Wei, Y.1    Zhang, Z.2    Liao, H.3    Wu, L.4    Wu, X.5    Zhou, D.6
  • 223
    • 79952488185 scopus 로고    scopus 로고
    • Therapeutic potential of beta-arrestin- and G protein-biased agonists
    • Whalen, E. J., Rajagopal, S., and Lefkowitz, R. J. (2011). Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends. Mol. Med. 17, 126-139.
    • (2011) Trends. Mol. Med. , vol.17 , pp. 126-139
    • Whalen, E.J.1    Rajagopal, S.2    Lefkowitz, R.J.3
  • 225
    • 84869842165 scopus 로고    scopus 로고
    • Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin
    • Willard, F. S., Wootten, D., Showalter, A. D., Savage, E. E., Ficorilli, J., Farb, T. B., et al. (2012). Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin. Mol. Pharmacol. 82, 1066-1073.
    • (2012) Mol. Pharmacol. , vol.82 , pp. 1066-1073
    • Willard, F.S.1    Wootten, D.2    Showalter, A.D.3    Savage, E.E.4    Ficorilli, J.5    Farb, T.B.6
  • 226
  • 227
    • 84875426039 scopus 로고    scopus 로고
    • Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands
    • Wootten, D., Savage, E. E., Willard, F. S., Bueno, A. B., Sloop, K. W., Christopoulos, A., et al. (2013). Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands. Mol. Pharmacol. 83, 822-834.
    • (2013) Mol. Pharmacol. , vol.83 , pp. 822-834
    • Wootten, D.1    Savage, E.E.2    Willard, F.S.3    Bueno, A.B.4    Sloop, K.W.5    Christopoulos, A.6
  • 228
    • 78149290612 scopus 로고    scopus 로고
    • Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo
    • Wu, Y. Q., Song, Z., Zhou, C. H., Xing, S. H., Pei, D. S., and Zheng, J. N. (2010). Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo. Oncol. Rep. 24, 1179-1184.
    • (2010) Oncol. Rep. , vol.24 , pp. 1179-1184
    • Wu, Y.Q.1    Song, Z.2    Zhou, C.H.3    Xing, S.H.4    Pei, D.S.5    Zheng, J.N.6
  • 229
    • 79954782236 scopus 로고    scopus 로고
    • Structure of an agonist-bound human A2A adenosine receptor
    • Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z. G., et al. (2011). Structure of an agonist-bound human A2A adenosine receptor. Science 332, 322-327.
    • (2011) Science , vol.332 , pp. 322-327
    • Xu, F.1    Wu, H.2    Katritch, V.3    Han, G.W.4    Jacobson, K.A.5    Gao, Z.G.6
  • 230
    • 0033513455 scopus 로고    scopus 로고
    • Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats
    • Xu, G., Stoffers, D. A., Habener, J. F., and Bonner-Weir, S. (1999). Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48, 2270-2276.
    • (1999) Diabetes , vol.48 , pp. 2270-2276
    • Xu, G.1    Stoffers, D.A.2    Habener, J.F.3    Bonner-Weir, S.4
  • 231
    • 28544441759 scopus 로고    scopus 로고
    • Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer
    • Yeh, A. H., Jeffery, P. L., Duncan, R. P., Herington, A. C., and Chopin, L. K. (2005). Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin. Cancer Res. 11, 8295-8303.
    • (2005) Clin. Cancer Res. , vol.11 , pp. 8295-8303
    • Yeh, A.H.1    Jeffery, P.L.2    Duncan, R.P.3    Herington, A.C.4    Chopin, L.K.5
  • 232
    • 39149108820 scopus 로고    scopus 로고
    • The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer
    • Yoo, Y. A., Kim, Y. H., Kim, J. S., and Seo, J. H. (2008). The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer. Biochim. Biophys. Acta 1783, 438-447.
    • (2008) Biochim. Biophys. Acta , vol.1783 , pp. 438-447
    • Yoo, Y.A.1    Kim, Y.H.2    Kim, J.S.3    Seo, J.H.4
  • 233
    • 36549062060 scopus 로고    scopus 로고
    • Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors
    • Younan, S. M., and Rashed, L. A. (2007). Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors. Gen. Physiol. Biophys. 26, 181-193.
    • (2007) Gen. Physiol. Biophys. , vol.26 , pp. 181-193
    • Younan, S.M.1    Rashed, L.A.2
  • 234
    • 67649856866 scopus 로고    scopus 로고
    • Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
    • Zidar, D. A., Violin, J. D., Whalen, E. J., and Lefkowitz, R. J. (2009). Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc. Natl. Acad. Sci. U.S.A. 106, 9649-9654.
    • (2009) Proc. Natl. Acad. Sci. U.S.A. , vol.106 , pp. 9649-9654
    • Zidar, D.A.1    Violin, J.D.2    Whalen, E.J.3    Lefkowitz, R.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.